Categories Health Care, U.S. Markets News

Celgene stock jumps after advisory firm backs merger with Bristol-Myers Squibb

The planned acquisition of Celgene (CELG) by rival drugmaker Bristol-Myers Squibb (BMY) got a new lease of life this week after proxy advisory firm Institutional Shareholder Services recommended Bristol-Myers shareholders to support it. The $74 billion deal has been in limbo following objection from a section of investors who own stake in Bristol-Myers.

Celgene’s stock gained about 8% in early trading Friday as shareholders welcomed the intervention of ISS in the proposed merger. The stock rally began in the pre-market session and continued after regular trading started.

In a letter sent to the shareholders, ISS termed the valuation ‘reasonable’ and opined that the transaction has a strong strategic rationale. The recommendation is in stark contrast to the negative stance adopted by activist investor Starboard Value and Bristol-Myers stakeholder Wellington Management earlier, saying the deal is ill-advised and poorly conceived.

According to Starboard, Celgene’s drug pipeline is very risky and it faces headwinds to revenue growth from the expiration of key patents in the next few years. Wellington Management believes the acquisition of Celgene will not help Bristol-Myers in achieving its business goals and enhancing the top-line performance in the future.

Also see: Bristol-Myers Squibb Company Q4 2018 Earnings Conference Call Transcript

Bristol-Myers shareholders are scheduled to vote on the closely-watched buyout on Tuesday. Meanwhile, advisory service Glass Lewis has also taken a stance supporting the deal.

As per an agreement reached by the companies when the acquisition was conceived in early January, Celgene shareholders will get one Bristol-Myers share and $50 in cash for each Celgene share. In addition, they will be eligible for a special rights issue, to be paid off once the combined entity meets certain financial milestones.

For the December-quarter, Celgene reported a 16% growth in revenues to about $4 billion, driving adjusted earnings higher by 20%. Benefitting from a decline in research and development costs, the company turned to a net profit during the quarter, on a reported basis.

After slipping to a five-year low in the final weeks of 2018, Celgene shares have gained more than 50%, once again crossing the $90-mark. The stock rose around 40% since the beginning of the year.

Meanwhile,  Bristol-Myers traded down 1% in the early trading hours on Friday, continuing the downturn that started mid-March. Currently, the stock is down 25% from the levels seen a year ago.


Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

Micron Technology (MU) Q3 Earnings: Key financials and quarterly highlights

Micron Technology Inc. (NASDAQ: MU) reported third quarter 2022 earnings results today. Revenue increased 16% year-over-year to $8.64 billion. GAAP net income was $2.63 billion, or $2.34 per share, compared

Constellation Brands (STZ): Earnings beat and share structure revamp put brewer in the spotlight

Shares of Constellation Brands Inc. (NYSE: STZ) were down 4% on Thursday despite the company beating expectations on its first quarter 2023 earnings results. The stock has dropped 7% year-to-date.

Infographic: Key highlights from Constellation Brands (STZ) Q1 2023 earnings results

Constellation Brands, Inc. (NYSE: STZ) reported first quarter 2023 earnings results today. Net sales increased 17% year-over-year to $2.3 billion. Net income attributable to CBI was $390 million, or $2.06


  1. Pingback: ไฮโล
  2. Pingback: Heavy News
  3. Pingback: ff tools
  4. Pingback: ff tool hack
  5. Pingback: venco
  6. Pingback: TikTok 18
  7. Pingback: enlevement epave
  8. Pingback: Epaviste gratuit
  9. Pingback: enlevement epave
  10. Pingback: naza
  11. Pingback: Buy Weed Online
  12. Pingback: ps5 on sale
  13. Pingback: WordPress Hosting
  14. Pingback: WordPress Hosting
  15. Pingback: WordPress Hosting
  16. Pingback: Epaviste gratuit
  17. Pingback: enlevement epave
  18. Pingback: berry pie strain
  19. Pingback: infused edibles
  20. Pingback: 500mg thc edibles
  21. Pingback: CZ P10C
  22. Pingback: Glock 43x for Sale
  23. Pingback: curepod battery
  24. Pingback: Buy This Domain
  25. Pingback: fishscale cocaine
  26. Pingback: classic books
  27. Pingback: promo models
  28. Pingback: Las Vegas models
  29. Pingback: Promotional models
  30. Pingback: Buy This Domain
  31. Pingback: pgslot
  32. Pingback: สล็อต
  33. Pingback: HP Envy 6000
  34. Pingback: fast typing speed
  35. Pingback: vintage posters
  36. Pingback: karen ball books
  37. Pingback: vintage posters
  38. Pingback: buy weed in dubai
Add Comment
Viewing Highlight